Pod Engine
Podcast thumbnail for Johnson & Johnson News Daily

Johnson & Johnson News Daily

Claim This Podcast

by Inception Point AI

389 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸
50

Podcast Authority

Beta
FairBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality99
Social0
YouTube0
Engagement0
Learn more

Podcast Overview

Stay informed with "Johnson & Johnson News Daily," the essential podcast for tracking JNJ stock and staying updated on all things Johnson & Johnson. Our daily episodes deliver the latest news, expert insights, and valuable information on company developments, market trends, and financial performance. Whether you're an investor, industry professional, or simply interested in one of the world's leading healthcare companies, tune in to stay ahead of the curve with "Johnson & Johnson News Daily." For more info go to https://www.quietperiodplease.com Check out these deals https://amzn.to/3zlo77e Also check out https://podcasts.apple.com/us/channel/what-to-do-in-city-guides/id6615091666 This content was created in partnership and with the help of Artificial Intelligence AI.

Language

🇺🇲

Publishing Since

11/8/2024

Visit WebsiteAppleView on Apple PodcastsRSS Feed

Unlock The Full Podcast Authority Score Report

See how your podcast performs across key metrics

50

Podcast Authority

Beta
FairBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality99
Social0
YouTube0
Engagement0
Learn more
8
Excellent Areas
3
Good Performance
8
Growth Opportunities
excellent
Publishing Consistency
Every 1 days
Performing excellently!
good
Show Notes Quality
3.0/5

Recommendations available

Unlock the full report to see detailed tips

poor
Episode Thumbnails

Recommendations available

Unlock the full report to see detailed tips

+16 More Metrics

Unlock comprehensive insights including:

  • • YouTube presence analysis
  • • Social media reach metrics
  • • RSS compliance scoring
  • • Podcast 2.0 features
  • • Technical standards
What's Included in Your Full Report

Detailed Analytics

  • Complete breakdown of all 19 authority metrics
  • Personalized recommendations for each metric
  • Industry benchmarks and comparisons
  • Technical RSS feed analysis and compliance scoring

Growth Strategies

  • Step-by-step action plans for improvement
  • Quick wins to boost your score immediately
  • Pro tips from successful podcasters
Get your free podcast insights report

See how your show performs across every key metric

Instant delivery
No spam
Attract Better Guests

High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.

Secure Sponsorships

Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.

Grow Your Audience

Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.

2 verified contact emails on file for Johnson & Johnson News Daily

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

See contact details

Recent Episodes

Episode thumbnail for Johnson and Johnson Stock Holds Steady as Investors Await Next Catalyst

June 19, 2026

Johnson and Johnson Stock Holds Steady as Investors Await Next Catalyst

# Johnson & Johnson Stock Analysis: Trading Update & Strategic Investment Focus | JNJ Stock Podcast Dive into the latest **Johnson & Johnson (JNJ) stock analysis** as we examine recent trading activity around the $228 price level. This episode covers JNJ's current market position within its 52-week trading range, below-average trading volume signaling investor caution, and what it means for shareholders. We explore **two critical themes shaping J&J's future**: the company's strategic focus on core healthcare and medical technology businesses following portfolio simplification, and ongoing legal challenges related to historical product liability cases. Discover why **Wall Street analysts remain constructive** on this defensive blue-chip stock, with Johnson & Johnson's significant R&D investments and major U.S. manufacturing expansion signaling long-term growth potential. Learn why lower trading volume suggests a "wait and see" approach as the market anticipates the next catalyst—earnings reports or regulatory updates. Whether you're a long-term investor seeking **dividend stability** or monitoring **healthcare sector opportunities**, this podcast delivers essential insights into one of America's most established pharmaceutical and medical device companies. **Topics covered:** - Latest JNJ stock price movement and technical levels - Johnson & Johnson's strategic business focus - Analyst ratings and price target outlook - Manufacturing and jobs investment in America - Why J&J remains a core portfolio holding *Subscribe for regular updates on blue-chip healthcare stocks and market analysis.* --- *A Quiet Please Production | Visit quietplease.ai for more investment podcasts* For more http://www.quietplease.ai Stock up on these deals https://amzn.to/3QFpYIX

Episode thumbnail for Johnson and Johnson Stock Holds Steady: Dividend Appeal and Stable Healthcare Holdings

June 18, 2026

Johnson and Johnson Stock Holds Steady: Dividend Appeal and Stable Healthcare Holdings

# SEO-Friendly Podcast Episode Description ## Johnson & Johnson (JNJ) Stock Analysis: Trading Update, Analyst Ratings & Investment Outlook Dive into the latest **Johnson & Johnson stock analysis** in this comprehensive market update. Currently trading at **$235.18 on the NYSE**, JNJ stock continues to demonstrate its reputation as a **blue-chip healthcare investment**. In this episode, we cover: 📊 **Current Trading Data**: Real-time JNJ stock price, daily trading volume (averaging 7.7M shares), and intraday price ranges 💼 **Company Fundamentals**: Johnson & Johnson's position as a diversified pharmaceutical and medical technology leader, including portfolio simplification strategies following the consumer health separation 💰 **Dividend Investment Focus**: Why income-focused investors continue to favor JNJ's consistent dividend record and defensive profile 📈 **Wall Street Analyst Ratings**: Consensus outlook showing hold-to-buy ratings with price targets in the mid-to-high $200s, indicating fairly valued to modestly undervalued positioning 🔬 **Pipeline & Growth Catalysts**: Ongoing investments in pharmaceutical and medical technology development driving long-term value **Perfect for**: Long-term investors, dividend seekers, healthcare sector watchers, and anyone tracking large-cap pharmaceutical stocks. **Keywords**: Johnson & Johnson stock, JNJ stock analysis, pharmaceutical stocks, dividend investing, healthcare sector, NYSE trading, blue-chip stocks, medical technology stocks --- *A Quiet Please Production | Subscribe for daily market insights | Visit quietplease.ai* For more http://www.quietplease.ai Stock up on these deals https://amzn.to/3QFpYIX

Episode thumbnail for Johnson and Johnson Stock Analysis: Dividend Strength and Technical Bullish Signals

June 17, 2026

Johnson and Johnson Stock Analysis: Dividend Strength and Technical Bullish Signals

# SEO-Friendly Podcast Episode Description ## Johnson & Johnson Stock Analysis: Navigating Cancer Trial Setback & Bullish Analyst Outlook | JNJ Stock Update Dive into the latest **Johnson & Johnson (NYSE: JNJ) stock analysis** as we examine the healthcare giant's current trading position at $236.40 per share. In this episode, we break down: 📊 **Technical Analysis & Market Performance:** - JNJ stock trades in a bullish trend above key moving averages - Recent 1.86% daily decline following cancer drug trial news - Trading volume of 2.71 million shares reflects normal liquidity 💰 **Dividend Income Highlights:** - Annual dividend of $5.36 per share - Attractive 2.25-2.5% dividend yield for income investors - Quarterly payment schedule maintains J&J's dividend aristocrat status 📈 **Analyst Coverage & Price Targets:** - HSBC upgrades price target from $265 to $280 with buy rating - Institutional investors actively rebalancing positions - Strong bullish sentiment despite short-term headwinds 🔬 **Breaking Healthcare News:** - Impact of cancelled cancer drug trial presentation - Pharmaceutical pipeline developments and R&D updates - Medical technology and diversified healthcare portfolio strength **Perfect for:** Value investors, dividend seekers, healthcare sector followers, and anyone tracking large-cap pharmaceutical stocks. **Keywords:** Johnson & Johnson stock, JNJ analysis, healthcare stocks, dividend aristocrats, pharmaceutical investing, cancer drug trials, medical technology stocks, blue-chip investments Subscribe for more healthcare sector insights and stock market analysis! *A Quiet Please Production | Visit quietplease.ai* For more http://www.quietplease.ai Stock up on these deals https://amzn.to/3QFpYIX

389 total episodes available

Deep-dive analytics for Johnson & Johnson News Daily

Sign up to explore

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Johnson & Johnson News Daily?

Stay informed with "Johnson & Johnson News Daily," the essential podcast for tracking JNJ stock and staying updated on all things Johnson & Johnson. Our daily episodes deliver the latest news, expert insights, and valuable information on company developments, market trends, and financial performance. Whether you're an investor, industry professional, or simply interested in one of the world's leading healthcare companies, tune in to stay ahead of the curve with "Johnson & Johnson News Daily."

For more info go to https://www.quietperiodplease.com

Check out these deals https://amzn.to/3zlo77e

Also check out https://podcasts.apple.com/us/channel/what-to-do-in-city-guides/id6615091666

This content was created in partnership and with the help of Artificial Intelligence AI.

How often does this podcast release new episodes?

This podcast updates daily.

Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.